Skip to content
GenoLensGenoLens

GLRA2

Chr Xp22.2

glycine receptor alpha 2

MANE:
ENST00000218075.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Early onset or syndromic epilepsy

    X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
  • Intellectual disability

    X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Disease associations (Open Targets)

  • intellectual developmental disorder, X-linked, syndromic, Pilorge type

    0.78
  • neurodegenerative disease

    0.34
  • hereditary disease

    0.19
  • autoimmune disorder of central nervous system

    0.14
  • myopia

    0.12
  • Rolandic epilepsy

    0.09
  • juvenile myoclonic epilepsy

    0.09
  • Lennox-Gastaut syndrome

    0.08
  • benign adult familial myoclonic epilepsy

    0.08
  • autism

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Glycine receptor subunit alpha-2

Subunit of heteromeric glycine-gated chloride channels (PubMed:15302677, PubMed:16144831, PubMed:2155780, PubMed:23895467, PubMed:25445488, PubMed:26370147, PubMed:34473954). Plays a role in synaptic plasticity (By similarity). Contributes to the generation of inhibitory postsynaptic currents, and is involved in the down-regulation of neuronal excitability (PubMed:25445488). Plays a role in cellular responses to ethanol (PubMed:23895467)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.